Further insights
“Immutep (ASX:IMM) plunged 35% this morning after releasing its topline results from the TACTI-003 Phase IIb Trial in First Line Head and Neck Cancer.
Source: theaustralian
IMM sinks despite cancer treatment trial success
https://search.app/Afbb9bej4bmCmzpC6
$100 million capital raising done and dusted, page-28
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
-0.005(1.64%) |
Mkt cap ! $436.3M | |||
| Open | High | Low | Value | Volume |
| 30.5¢ | 31.3¢ | 30.0¢ | $960.6K | 3.161M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 188729 | 30.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 46153 | 2 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| IMM (ASX) Chart |